-
Entity
-
Individual
-
Location
-
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4, Ireland
-
Summary
-
The estimated net worth of Karen L. Smith is at least $251 K dollars as of July 5, 2024. Karen L. Smith is the Chief Medical Officer of Quince Therapeutics, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $183 K. Karen L. Smith is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $46.3 K. Karen L. Smith is the EVP, Chief Medical Officer of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $21.6 K.